Premium
Does long‐term entecavir treatment really reduce hepatocellular carcinoma incidence in patients with hepatitis B virus infection?
Author(s) -
Lo GinHo
Publication year - 2014
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.26773
Subject(s) - entecavir , hepatocellular carcinoma , medicine , propensity score matching , incidence (geometry) , cirrhosis , hepatitis b virus , gastroenterology , hepatology , hepatitis b , retrospective cohort study , immunology , virus , lamivudine , physics , optics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom